At 6 weeks after I/R injury, GSK854 treated animals showed reduced atrial natriuretic peptide precursor (pro-ANP) levels, smaller CM areas, and less cardiac fibrosis versus control vehicle-treated mice, indicating decreased heart failure progression [2]. This evidence concerns the gene NPPA and heart failure.